Concepts (324)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fatty Acid Desaturases | 8 | 2021 | 51 | 1.100 |
Why?
|
| Phospholipases A | 14 | 2005 | 31 | 0.940 |
Why?
|
| Fatty Acids, Omega-3 | 4 | 2021 | 70 | 0.820 |
Why?
|
| Neutrophils | 16 | 2016 | 123 | 0.790 |
Why?
|
| Pulmonary Surfactants | 6 | 2012 | 17 | 0.750 |
Why?
|
| Blood-Brain Barrier | 4 | 2025 | 52 | 0.750 |
Why?
|
| Asthma | 7 | 2021 | 274 | 0.720 |
Why?
|
| Arachidonic Acid | 10 | 2015 | 41 | 0.670 |
Why?
|
| Linoleic Acid | 4 | 2023 | 20 | 0.600 |
Why?
|
| Inflammation | 8 | 2020 | 557 | 0.580 |
Why?
|
| Eosinophils | 5 | 2009 | 32 | 0.570 |
Why?
|
| Phosphatidylglycerols | 4 | 2012 | 8 | 0.570 |
Why?
|
| Multigene Family | 4 | 2021 | 54 | 0.560 |
Why?
|
| Dietary Supplements | 2 | 2017 | 198 | 0.540 |
Why?
|
| Phospholipids | 3 | 2021 | 35 | 0.530 |
Why?
|
| Plant Oils | 3 | 2020 | 17 | 0.500 |
Why?
|
| Respiratory Distress Syndrome, Adult | 4 | 2015 | 51 | 0.490 |
Why?
|
| Fatty Acids, Omega-6 | 5 | 2017 | 36 | 0.450 |
Why?
|
| Phospholipases A2, Secretory | 2 | 2024 | 3 | 0.430 |
Why?
|
| Gold | 2 | 2024 | 19 | 0.380 |
Why?
|
| Metal Nanoparticles | 2 | 2024 | 17 | 0.370 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 1 | 2011 | 1 | 0.360 |
Why?
|
| Group IA Phospholipases A2 | 1 | 2011 | 1 | 0.360 |
Why?
|
| Group IB Phospholipases A2 | 1 | 2011 | 1 | 0.360 |
Why?
|
| Organoids | 2 | 2024 | 99 | 0.340 |
Why?
|
| Dietary Fats | 2 | 2009 | 115 | 0.330 |
Why?
|
| Humans | 48 | 2025 | 34562 | 0.320 |
Why?
|
| gamma-Linolenic Acid | 3 | 2020 | 11 | 0.300 |
Why?
|
| Fatty Acids, Unsaturated | 3 | 2020 | 43 | 0.300 |
Why?
|
| Hydrolysis | 6 | 2021 | 42 | 0.290 |
Why?
|
| Models, Biological | 2 | 2020 | 432 | 0.270 |
Why?
|
| Genetic Variation | 2 | 2021 | 254 | 0.270 |
Why?
|
| Hyperlipidemias | 1 | 2008 | 61 | 0.260 |
Why?
|
| Bronchoalveolar Lavage Fluid | 5 | 2012 | 62 | 0.250 |
Why?
|
| Diet | 3 | 2023 | 418 | 0.240 |
Why?
|
| Immune System | 1 | 2025 | 7 | 0.230 |
Why?
|
| Surface-Active Agents | 2 | 2021 | 7 | 0.220 |
Why?
|
| DNA Methylation | 2 | 2017 | 147 | 0.220 |
Why?
|
| Lung | 5 | 2004 | 279 | 0.220 |
Why?
|
| Animals | 15 | 2025 | 8578 | 0.220 |
Why?
|
| Multiple Sclerosis | 1 | 2025 | 62 | 0.210 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2020 | 1079 | 0.210 |
Why?
|
| Doxorubicin | 1 | 2024 | 92 | 0.200 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 5 | 1998 | 7 | 0.200 |
Why?
|
| Eicosanoids | 2 | 2021 | 9 | 0.200 |
Why?
|
| Acute Lung Injury | 2 | 2015 | 37 | 0.200 |
Why?
|
| Graphite | 1 | 2022 | 5 | 0.190 |
Why?
|
| Phospholipases A2 | 10 | 2005 | 25 | 0.190 |
Why?
|
| Energy Intake | 1 | 2023 | 138 | 0.190 |
Why?
|
| Inflammation Mediators | 2 | 2003 | 108 | 0.190 |
Why?
|
| Glioblastoma | 1 | 2024 | 161 | 0.190 |
Why?
|
| Diglycerides | 2 | 1998 | 4 | 0.180 |
Why?
|
| Organ Specificity | 2 | 2018 | 86 | 0.180 |
Why?
|
| Group X Phospholipases A2 | 1 | 2021 | 1 | 0.170 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2021 | 3 | 0.170 |
Why?
|
| Indians, North American | 1 | 2021 | 110 | 0.170 |
Why?
|
| Bone Neoplasms | 1 | 2022 | 122 | 0.170 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2007 | 227 | 0.160 |
Why?
|
| Spheroids, Cellular | 1 | 2020 | 39 | 0.160 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 113 | 0.160 |
Why?
|
| alpha-Linolenic Acid | 2 | 2017 | 12 | 0.160 |
Why?
|
| Fluorescent Dyes | 1 | 2020 | 55 | 0.160 |
Why?
|
| Soybean Oil | 1 | 2020 | 9 | 0.160 |
Why?
|
| Sputum | 3 | 2021 | 17 | 0.160 |
Why?
|
| Metabolomics | 1 | 2020 | 65 | 0.160 |
Why?
|
| Flow Cytometry | 6 | 2016 | 198 | 0.160 |
Why?
|
| Respiratory Burst | 2 | 2016 | 5 | 0.150 |
Why?
|
| Group II Phospholipases A2 | 4 | 2024 | 5 | 0.150 |
Why?
|
| Epithelial Cells | 1 | 2000 | 148 | 0.150 |
Why?
|
| Endothelium, Vascular | 1 | 2020 | 163 | 0.150 |
Why?
|
| Enzyme Activation | 4 | 2009 | 148 | 0.150 |
Why?
|
| Dietary Fats, Unsaturated | 2 | 2009 | 28 | 0.140 |
Why?
|
| Phosphatidylcholines | 3 | 2011 | 29 | 0.140 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2017 | 24 | 0.130 |
Why?
|
| Quantitative Trait Loci | 1 | 2018 | 142 | 0.130 |
Why?
|
| Nutritional Status | 1 | 2017 | 80 | 0.130 |
Why?
|
| Neurons | 1 | 2020 | 491 | 0.120 |
Why?
|
| Lysophospholipids | 3 | 2005 | 27 | 0.120 |
Why?
|
| Docosahexaenoic Acids | 1 | 2015 | 25 | 0.120 |
Why?
|
| Temporal Lobe | 1 | 2015 | 35 | 0.120 |
Why?
|
| Liver | 2 | 2015 | 513 | 0.120 |
Why?
|
| Exercise | 1 | 2021 | 701 | 0.120 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 110 | 0.110 |
Why?
|
| Wasting Syndrome | 1 | 2015 | 14 | 0.110 |
Why?
|
| Physical Conditioning, Animal | 1 | 2015 | 36 | 0.110 |
Why?
|
| Brain | 1 | 2020 | 1031 | 0.100 |
Why?
|
| Cytosol | 5 | 2005 | 27 | 0.100 |
Why?
|
| Genotype | 3 | 2020 | 744 | 0.100 |
Why?
|
| Exercise Therapy | 1 | 2015 | 283 | 0.090 |
Why?
|
| Bronchi | 2 | 2004 | 41 | 0.090 |
Why?
|
| Early Diagnosis | 1 | 2012 | 62 | 0.090 |
Why?
|
| Triglycerides | 2 | 2008 | 249 | 0.090 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 526 | 0.090 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2011 | 4 | 0.090 |
Why?
|
| Cattle | 1 | 2011 | 118 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 498 | 0.090 |
Why?
|
| Sheep | 1 | 2011 | 233 | 0.080 |
Why?
|
| Cytokines | 2 | 2024 | 269 | 0.080 |
Why?
|
| Adult | 7 | 2024 | 10030 | 0.080 |
Why?
|
| Biological Transport | 2 | 2020 | 76 | 0.080 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 575 | 0.080 |
Why?
|
| Fatty Acids | 3 | 2009 | 108 | 0.080 |
Why?
|
| Oxygen | 3 | 1986 | 152 | 0.080 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2009 | 6 | 0.070 |
Why?
|
| Interleukin-5 | 1 | 2009 | 7 | 0.070 |
Why?
|
| Acyltransferases | 1 | 2009 | 18 | 0.070 |
Why?
|
| Fish Oils | 1 | 2009 | 40 | 0.070 |
Why?
|
| Caspases | 1 | 2009 | 44 | 0.070 |
Why?
|
| Linseed Oil | 1 | 2008 | 2 | 0.070 |
Why?
|
| Calgranulin A | 1 | 2007 | 2 | 0.070 |
Why?
|
| Echium | 1 | 2008 | 11 | 0.070 |
Why?
|
| Calgranulin B | 1 | 2007 | 3 | 0.070 |
Why?
|
| S100 Proteins | 1 | 2007 | 20 | 0.070 |
Why?
|
| Cystic Fibrosis | 2 | 2007 | 25 | 0.070 |
Why?
|
| Cells, Cultured | 4 | 2020 | 889 | 0.070 |
Why?
|
| Lung Diseases | 1 | 2007 | 51 | 0.070 |
Why?
|
| Granulocytes | 1 | 2007 | 13 | 0.070 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2007 | 11 | 0.070 |
Why?
|
| HMGB1 Protein | 1 | 2007 | 11 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2007 | 36 | 0.070 |
Why?
|
| Male | 7 | 2024 | 20739 | 0.060 |
Why?
|
| Endotoxins | 1 | 2007 | 37 | 0.060 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2007 | 32 | 0.060 |
Why?
|
| Dexamethasone | 1 | 2007 | 52 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2008 | 771 | 0.060 |
Why?
|
| COS Cells | 3 | 2004 | 33 | 0.060 |
Why?
|
| Cholesterol | 1 | 2008 | 273 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2007 | 157 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2008 | 439 | 0.060 |
Why?
|
| Glucocorticoids | 1 | 2007 | 154 | 0.060 |
Why?
|
| Interleukin-1 | 1 | 2005 | 51 | 0.060 |
Why?
|
| Dinoprostone | 1 | 2005 | 37 | 0.060 |
Why?
|
| Trachea | 1 | 2005 | 56 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 281 | 0.060 |
Why?
|
| Apoptosis | 1 | 2007 | 400 | 0.060 |
Why?
|
| Mast Cells | 2 | 1995 | 13 | 0.060 |
Why?
|
| Female | 6 | 2024 | 21531 | 0.060 |
Why?
|
| Muscle, Smooth | 1 | 2005 | 152 | 0.050 |
Why?
|
| Allergens | 1 | 2004 | 16 | 0.050 |
Why?
|
| European Continental Ancestry Group | 2 | 2020 | 1176 | 0.050 |
Why?
|
| Mucus | 1 | 2004 | 4 | 0.050 |
Why?
|
| Respiratory Mucosa | 1 | 2004 | 12 | 0.050 |
Why?
|
| Mucins | 1 | 2004 | 18 | 0.050 |
Why?
|
| Cell Line | 2 | 2007 | 476 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2024 | 63 | 0.050 |
Why?
|
| Middle Aged | 4 | 2024 | 12726 | 0.050 |
Why?
|
| Kinetics | 2 | 2009 | 259 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2007 | 545 | 0.050 |
Why?
|
| Young Adult | 2 | 2021 | 2831 | 0.050 |
Why?
|
| Vegetables | 1 | 2023 | 41 | 0.050 |
Why?
|
| Proteomics | 1 | 2024 | 106 | 0.050 |
Why?
|
| Ribonucleases | 1 | 2003 | 7 | 0.050 |
Why?
|
| Substrate Specificity | 2 | 2000 | 91 | 0.050 |
Why?
|
| Fruit | 1 | 2023 | 57 | 0.050 |
Why?
|
| Blood Proteins | 1 | 2003 | 20 | 0.050 |
Why?
|
| Aged | 3 | 2024 | 11022 | 0.050 |
Why?
|
| Saliva | 1 | 2003 | 41 | 0.050 |
Why?
|
| Electroplating | 1 | 2022 | 2 | 0.050 |
Why?
|
| Transfection | 2 | 2000 | 216 | 0.050 |
Why?
|
| Durapatite | 1 | 2022 | 10 | 0.050 |
Why?
|
| Porosity | 1 | 2022 | 41 | 0.050 |
Why?
|
| Phosphorylation | 3 | 1998 | 264 | 0.050 |
Why?
|
| Bone Regeneration | 1 | 2022 | 33 | 0.050 |
Why?
|
| Osteogenesis | 1 | 2022 | 81 | 0.050 |
Why?
|
| Nutrition Surveys | 1 | 2023 | 156 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 781 | 0.040 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 1998 | 28 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2008 | 837 | 0.040 |
Why?
|
| Heredity | 1 | 2021 | 14 | 0.040 |
Why?
|
| Bronchoconstriction | 1 | 2021 | 3 | 0.040 |
Why?
|
| Osmotic Pressure | 1 | 2021 | 17 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 922 | 0.040 |
Why?
|
| Adolescent | 3 | 2021 | 3805 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2000 | 48 | 0.040 |
Why?
|
| Histocytochemistry | 1 | 2000 | 35 | 0.040 |
Why?
|
| Cell Membrane Permeability | 1 | 2020 | 19 | 0.040 |
Why?
|
| Pericytes | 1 | 2020 | 32 | 0.040 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 2020 | 14 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 77 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2000 | 72 | 0.040 |
Why?
|
| Astrocytes | 1 | 2020 | 64 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 104 | 0.040 |
Why?
|
| Surface Tension | 3 | 2005 | 6 | 0.040 |
Why?
|
| Models, Immunological | 1 | 1999 | 9 | 0.040 |
Why?
|
| Tissue Scaffolds | 1 | 2022 | 435 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2020 | 204 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 802 | 0.040 |
Why?
|
| African Americans | 2 | 2017 | 1435 | 0.040 |
Why?
|
| Synovial Fluid | 1 | 1998 | 8 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 1607 | 0.040 |
Why?
|
| Lipids | 1 | 2020 | 267 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2020 | 597 | 0.040 |
Why?
|
| Swine | 3 | 2005 | 233 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2024 | 649 | 0.040 |
Why?
|
| Lung Injury | 1 | 1999 | 68 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2020 | 265 | 0.040 |
Why?
|
| Blotting, Western | 1 | 1998 | 328 | 0.030 |
Why?
|
| CpG Islands | 1 | 2017 | 45 | 0.030 |
Why?
|
| Protein Kinases | 1 | 1997 | 34 | 0.030 |
Why?
|
| Cell Separation | 1 | 1998 | 93 | 0.030 |
Why?
|
| Demography | 1 | 2017 | 112 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 142 | 0.030 |
Why?
|
| Biological Products | 1 | 1998 | 80 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2022 | 700 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2016 | 76 | 0.030 |
Why?
|
| Phagocytes | 1 | 1995 | 6 | 0.030 |
Why?
|
| Blood Cells | 1 | 1995 | 9 | 0.030 |
Why?
|
| Sexual Maturation | 1 | 2015 | 28 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 1910 | 0.030 |
Why?
|
| Superoxides | 1 | 1995 | 24 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 282 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2007 | 145 | 0.030 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 1 | 2015 | 9 | 0.030 |
Why?
|
| Pulmonary Alveoli | 1 | 2015 | 20 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2015 | 27 | 0.030 |
Why?
|
| Chemokines | 1 | 2015 | 36 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2015 | 43 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2015 | 69 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 122 | 0.030 |
Why?
|
| Muscular Atrophy | 1 | 2015 | 77 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2015 | 842 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 2463 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2014 | 189 | 0.030 |
Why?
|
| Alleles | 1 | 2014 | 261 | 0.030 |
Why?
|
| Hydrogen Peroxide | 2 | 1985 | 87 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2014 | 138 | 0.020 |
Why?
|
| Influenza A virus | 2 | 1990 | 24 | 0.020 |
Why?
|
| United States | 1 | 2021 | 4278 | 0.020 |
Why?
|
| Motor Activity | 1 | 2015 | 356 | 0.020 |
Why?
|
| Fluoresceins | 3 | 1986 | 9 | 0.020 |
Why?
|
| Monocytes | 2 | 2007 | 141 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 1990 | 20 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 1128 | 0.020 |
Why?
|
| Acute Disease | 2 | 2007 | 277 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 2353 | 0.020 |
Why?
|
| Bone Resorption | 1 | 1989 | 13 | 0.020 |
Why?
|
| Leukotriene B4 | 1 | 2009 | 3 | 0.020 |
Why?
|
| Osteoclasts | 1 | 1989 | 25 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 1989 | 40 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 2 | 1990 | 99 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2009 | 60 | 0.020 |
Why?
|
| Bone and Bones | 1 | 1989 | 99 | 0.020 |
Why?
|
| RNA | 1 | 2009 | 100 | 0.020 |
Why?
|
| Membrane Potentials | 2 | 1985 | 80 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2007 | 16 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 165 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2007 | 27 | 0.020 |
Why?
|
| Calcium | 1 | 1989 | 343 | 0.020 |
Why?
|
| Necrosis | 1 | 2007 | 55 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 118 | 0.020 |
Why?
|
| Endocytosis | 1 | 1986 | 12 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 1209 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2007 | 258 | 0.010 |
Why?
|
| Risk Factors | 1 | 2014 | 4137 | 0.010 |
Why?
|
| Microsomes | 1 | 2005 | 13 | 0.010 |
Why?
|
| Models, Chemical | 1 | 2005 | 36 | 0.010 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2007 | 154 | 0.010 |
Why?
|
| Cyclooxygenase 1 | 1 | 2005 | 23 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 41 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 46 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 32 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 39 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2005 | 43 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2005 | 51 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2007 | 926 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1985 | 17 | 0.010 |
Why?
|
| Carbocyanines | 1 | 1985 | 6 | 0.010 |
Why?
|
| Phagocytosis | 1 | 1984 | 19 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2005 | 185 | 0.010 |
Why?
|
| Influenza, Human | 1 | 1986 | 133 | 0.010 |
Why?
|
| Antigen Presentation | 1 | 2004 | 10 | 0.010 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2004 | 15 | 0.010 |
Why?
|
| Mucin-5B | 1 | 2004 | 1 | 0.010 |
Why?
|
| Bronchitis | 1 | 2004 | 2 | 0.010 |
Why?
|
| Mucin 5AC | 1 | 2004 | 2 | 0.010 |
Why?
|
| Sepsis | 1 | 1986 | 167 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 1998 | 281 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 80 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2004 | 44 | 0.010 |
Why?
|
| Eosinophil Granule Proteins | 1 | 2003 | 2 | 0.010 |
Why?
|
| DNA | 1 | 2004 | 235 | 0.010 |
Why?
|
| Peroxidase | 2 | 1995 | 31 | 0.010 |
Why?
|
| Snake Venoms | 1 | 1998 | 2 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1998 | 10 | 0.010 |
Why?
|
| Mammals | 1 | 1998 | 16 | 0.010 |
Why?
|
| Pancreas | 1 | 1998 | 108 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 1997 | 12 | 0.010 |
Why?
|
| Child | 1 | 2004 | 2614 | 0.010 |
Why?
|
| Methacholine Chloride | 1 | 1997 | 2 | 0.010 |
Why?
|
| Bronchial Provocation Tests | 1 | 1997 | 6 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 1997 | 105 | 0.010 |
Why?
|
| Mice | 2 | 1994 | 2720 | 0.010 |
Why?
|
| Pulmonary Edema | 1 | 1995 | 13 | 0.010 |
Why?
|
| Cell Degranulation | 1 | 1995 | 2 | 0.010 |
Why?
|
| Chemotactic Factors | 1 | 1995 | 4 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1995 | 23 | 0.010 |
Why?
|
| Blood Platelets | 1 | 1995 | 61 | 0.010 |
Why?
|
| Cell Movement | 1 | 1995 | 182 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1994 | 7 | 0.010 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 1994 | 4 | 0.010 |
Why?
|
| Macrophages | 1 | 1995 | 216 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1990 | 21 | 0.010 |
Why?
|
| Actins | 1 | 1990 | 56 | 0.000 |
Why?
|
| Polyethylene Glycols | 1 | 1990 | 67 | 0.000 |
Why?
|
| Microfilament Proteins | 1 | 1990 | 38 | 0.000 |
Why?
|
| Acridine Orange | 1 | 1989 | 1 | 0.000 |
Why?
|
| Calcium Radioisotopes | 1 | 1989 | 1 | 0.000 |
Why?
|
| Calcitonin | 1 | 1989 | 4 | 0.000 |
Why?
|
| Acids | 1 | 1989 | 4 | 0.000 |
Why?
|
| Culture Techniques | 1 | 1989 | 14 | 0.000 |
Why?
|
| Parathyroid Hormone | 1 | 1989 | 47 | 0.000 |
Why?
|
| Pinocytosis | 1 | 1986 | 2 | 0.000 |
Why?
|
| Subcellular Fractions | 1 | 1986 | 15 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1986 | 43 | 0.000 |
Why?
|
| Cytoplasmic Granules | 1 | 1986 | 7 | 0.000 |
Why?
|
| Permeability | 1 | 1986 | 11 | 0.000 |
Why?
|
| Binding, Competitive | 1 | 1986 | 44 | 0.000 |
Why?
|
| Extracellular Space | 1 | 1986 | 28 | 0.000 |
Why?
|
| Free Radicals | 1 | 1986 | 10 | 0.000 |
Why?
|
| Blood Physiological Phenomena | 1 | 1984 | 2 | 0.000 |
Why?
|
| Opsonin Proteins | 1 | 1984 | 6 | 0.000 |
Why?
|
| Staphylococcus aureus | 1 | 1984 | 58 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1984 | 136 | 0.000 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1983 | 7 | 0.000 |
Why?
|